Comparative lead-in
Manufacturers must pick a tray that survives gamma irradiation and keeps ethylene oxide (EO) residuals within PPM limits. This article compares approaches and shows a clear architecture to meet limits. Visit Medtec China 2026 to see real examples from the show floor. Many teams bring these questions to the Shanghai stages at the China medical exhibition.
What breaks compliance
Problems are simple. Wrong polymer. Poor geometry. Hidden dead volume. High bioburden. Each raises EO uptake or stops dose penetration. Key industry anchors: ISO 11137 and ISO 10993-7. ISO 11137 sub-parts: Part 1 — Requirements for development, validation and routine control of a sterilization process for medical devices; Part 2 — Establishing the sterilization dose; Part 3 — Guidance on dosimetric aspects. ISO 10993-7 covers biological evaluation and residual limits for EO. Also respect a 14-day bioburden incubation for routine checks.
Core architecture principles
Keep it tight. Materials first. Use polymers proven for gamma. Limit density where dose must penetrate. Design venting paths for trapped gas. Match tray geometry to load patterns. Control stacking to avoid shadowing. Include sterilization validation features: dose mapping, biological indicators, and sterility assurance labeling. Key terms: gamma irradiation, bioburden, dose mapping.
Materials and geometry: side-by-side
Gamma-friendly polymers: high-density polyethylene (HDPE) and certain grades of polypropylene. EO-adsorbing materials: some foams and adhesives — avoid them. Thin walls help dose uniformity but reduce mechanical strength. Thick walls protect devices but cause shadowing. A good tray balances thickness, ribs, and vents. Use simple blind tests to compare residual EO PPM after standard cycles.
Validation and testing checklist
Do these steps and document each result. Use gas chromatography or equivalent for residual analysis. Tests to include: – Dose mapping across representative loads (record absorbed dose ranges). – Bioburden assessment with 14-day incubation for routine checks. – EO residual testing against chosen PPM acceptance criteria. – Mechanical integrity after gamma cycles. Standards to cite: ISO 11137 Parts 1, 2, 3; ISO 10993-7 for EO residual guidance. Validate sterilization process and packaging together — not separately.
Operational trade-offs
Gamma gives deep penetration and throughput. It can embrittle some plastics. EO leaves residues and needs aeration time. E-beam has shallower penetration but shorter cycles. Compare by test results, not claims. Measure residual EO PPM after typical shipping and aeration cycles. Track bioburden and sterility assurance level (SAL) during production runs.
Common mistakes to avoid
– Designing vents that clog during handling. – Assuming material labels guarantee gamma stability. – Testing empty trays only. – Skipping dose mapping with production loads. Teams often test nominal parts — then fail with full trays. — Keep validation realistic; simulate worst-case loads.
How to choose: quick decision criteria
Choose by evidence. Prefer trays with third-party dose mapping data. Require EO residual reports from real loads. Ask suppliers for post-irradiation mechanical data. Ensure packaging design and sterilization cycle are validated together. Consider serviceability in the field — trays must survive handling and sterilization repeatedly.
Advisory: three metrics to evaluate any solution
1) Residual EO PPM after full-cycle and after standard aeration — must meet your product’s acceptance criteria and ISO 10993-7 guidance. 2) Dose uniformity range from ISO 11137 Part 3 mapping — reported as min/max absorbed dose across typical loads. 3) Bioburden control proven by routine 14-day incubation results and trend data across batches.
Final line
Design and test with these metrics in hand; the result is predictable compliance — Medtec.
